Boston Private Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$3.5M Sell
48,101
-956
-2% -$68.1K 0.16% 142
2014
Q4
$3.38M Sell
49,057
-3,043
-6% -$205K 0.16% 141
2014
Q3
$3.38M Sell
52,100
-16,775
-24% -$1.06M 0.16% 140
2014
Q2
$4.28M Sell
68,875
-20,377
-23% -$1.22M 0.21% 129
2014
Q1
$5.25M Sell
89,252
-21,469
-19% -$1.2M 0.27% 113
2013
Q4
$5.65M Sell
110,721
-45,985
-29% -$2.3M 0.28% 107
2013
Q3
$7.89M Buy
156,706
+7,470
+5% +$391K 0.44% 75
2013
Q2
$7.33M Buy
+149,236
New +$8.12M 0.43% 72

Other funds holding LLY

Boston Private Bank & Trust's LLY Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its Eli Lilly (LLY) stake by 1.9% in Q1 2015, selling an estimated $68.1K and leaving 48,101 shares worth $3.5M. The position accounts for 0.16% of the portfolio, ranked #142.

Boston Private Bank & Trust first reported a position in LLY in Q2 2013 and has held it in 8 quarters since. The position peaked at $7.89M in Q3 2013. 1,118 funds tracked by Wall St. Rank hold LLY as of Q1 2015.

  • Boston Private Bank & Trust held 48,101 shares of Eli Lilly worth $3.5M as of Q1 2015.
  • Boston Private Bank & Trust sold 956 Eli Lilly shares in Q1 2015, an estimated $68.1K.
  • Eli Lilly made up 0.16% of Boston Private Bank & Trust's portfolio in Q1 2015, its #142 holding.
  • Boston Private Bank & Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 8 quarters since.
  • Boston Private Bank & Trust's Eli Lilly position peaked at $7.89M in Q3 2013.
  • 1,118 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.